Search research articles
Contact Us
Filters
Showing results (71-80 of 580) with videos related to
Page
of 58
Sort By:
The New England Journal of Medicine
|
August 23, 1990
Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component
P N Hawkins, J P Lavender, M B Pepys
British Journal of Haematology
|
December 29, 2007
Perspectives in treatment of AL amyloidosis
Ashutosh D Wechalekar, Philip N Hawkins, Julian D Gillmore
Kidney International
|
December 4, 2014
Emerging treatments for amyloidosis
Rabya H Sayed, Philip N Hawkins, Helen J Lachmann
The New England Journal of Medicine
|
June 20, 2003
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome
Philip N Hawkins, Helen J Lachmann, Michael F McDermott
Journal of Hepatology
|
June 17, 1999
Amyloidosis and the liver
J D Gillmore, L B Lovat, P N Hawkins
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 1, 1995
Treatment of amyloidosis
S Y Tan, M B Pepys, P N Hawkins
The Journal of Clinical Investigation
|
April 1, 1993
Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
D M Vigushin, M B Pepys, P N Hawkins
Microbial Ecology
|
January 15, 2014
Southern Appalachian peatlands support high archaeal diversity
A N Hawkins, K W Johnson, S L Bräuer
Equine Veterinary Journal. Supplement
|
October 31, 2002
Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate
M W Orth, T L Peters, J N Hawkins
Nature Reviews. Gastroenterology & Hepatology
|
September 3, 2009
Systemic amyloidosis and the gastrointestinal tract
Prayman T Sattianayagam, Philip N Hawkins, Julian D Gillmore
Page
of 58
Search research articles
Search
Showing results (71-80 of 580) with videos related to
Sort By:
Page
of 58
The New England Journal of Medicine
|
August 23, 1990
Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component
P N Hawkins, J P Lavender, M B Pepys
British Journal of Haematology
|
December 29, 2007
Perspectives in treatment of AL amyloidosis
Ashutosh D Wechalekar, Philip N Hawkins, Julian D Gillmore
Kidney International
|
December 4, 2014
Emerging treatments for amyloidosis
Rabya H Sayed, Philip N Hawkins, Helen J Lachmann
The New England Journal of Medicine
|
June 20, 2003
Interleukin-1-receptor antagonist in the Muckle-Wells syndrome
Philip N Hawkins, Helen J Lachmann, Michael F McDermott
Journal of Hepatology
|
June 17, 1999
Amyloidosis and the liver
J D Gillmore, L B Lovat, P N Hawkins
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 1, 1995
Treatment of amyloidosis
S Y Tan, M B Pepys, P N Hawkins
The Journal of Clinical Investigation
|
April 1, 1993
Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
D M Vigushin, M B Pepys, P N Hawkins
Microbial Ecology
|
January 15, 2014
Southern Appalachian peatlands support high archaeal diversity
A N Hawkins, K W Johnson, S L Bräuer
Equine Veterinary Journal. Supplement
|
October 31, 2002
Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate
M W Orth, T L Peters, J N Hawkins
Nature Reviews. Gastroenterology & Hepatology
|
September 3, 2009
Systemic amyloidosis and the gastrointestinal tract
Prayman T Sattianayagam, Philip N Hawkins, Julian D Gillmore
Page
of 58